Mirum Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Mirum Pharmaceuticals, Inc. (MIRM) had Shares Outstanding (Cover Page) of 64.93 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 64.93M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 60.98M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 60.34M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 51.39M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 64.93M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 60.98M shares 10-Q · filed 2026-05-06 |
| 2026-02-20 | 60.34M shares 10-K · filed 2026-02-25 |
| 2025-10-31 | 51.39M shares 10-Q · filed 2025-11-04 |
| 2025-08-01 | 50.24M shares 10-Q · filed 2025-08-06 |
| 2025-05-02 | 49.53M shares 10-Q · filed 2025-05-07 |
| 2025-02-21 | 49.01M shares 10-K · filed 2025-02-26 |
| 2024-11-08 | 48.00M shares 10-Q · filed 2024-11-12 |
| 2024-08-02 | 47.71M shares 10-Q · filed 2024-08-07 |
| 2024-05-03 | 47.13M shares 10-Q · filed 2024-05-08 |
| 2024-03-08 | 47.00M shares 10-K · filed 2024-03-15 |
| 2023-10-27 | 46.61M shares 10-Q · filed 2023-11-02 |
| 2023-07-28 | 38.30M shares 10-Q · filed 2023-08-07 |
| 2023-04-28 | 38.03M shares 10-Q · filed 2023-05-04 |
| 2023-03-03 | 37.95M shares 10-K · filed 2023-03-08 |
| 2022-11-04 | 36.87M shares 10-Q · filed 2022-11-09 |
| 2022-08-01 | 32.75M shares 10-Q · filed 2022-08-04 |
| 2022-05-02 | 31.84M shares 10-Q · filed 2022-05-05 |
| 2022-03-04 | 31.73M shares 10-K · filed 2022-03-09 |
| 2021-11-10 | 30.64M shares 10-Q · filed 2021-11-15 |
| 2021-07-30 | 30.52M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 30.45M shares 10-Q · filed 2021-05-06 |
| 2021-03-05 | 30.42M shares 10-K · filed 2021-03-09 |
| 2020-11-06 | 25.72M shares 10-Q · filed 2020-11-12 |
| 2020-07-31 | 25.40M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 25.39M shares 10-Q · filed 2020-05-07 |
| 2020-03-06 | 25.39M shares 10-K · filed 2020-03-12 |
| 2019-11-01 | 22.99M shares 10-Q · filed 2019-11-06 |
| 2019-08-26 | 22.99M shares 10-Q · filed 2019-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |